ReP USP - Resultado da busca

Artigo de periodico
Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats (2016)
Peres, Fernanda F.; Levin, Raquel; Suiama, Mayra A.; Diana, Mariana C.; Gouvêa, Douglas A.; Almeida, Valéria; Santos, Camila M.; Lungato, Lisandro; Zuardi, Antônio Waldo; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; D’Almeida, Vânia; Silva, Regina H.; Abílio, Vanessa C.
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: CANABINOIDES, DOENÇA DE PARKINSON, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERES, Fernanda F. et al. Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats. Frontiers in Pharmacology, v. 7, 2016Tradução . . Disponível em: https://doi.org/10.3389/fphar.2016.00343. Acesso em: 15 nov. 2024.
APA
Peres, F. F., Levin, R., Suiama, M. A., Diana, M. C., Gouvêa, D. A., Almeida, V., et al. (2016). Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats. Frontiers in Pharmacology, 7. doi:10.3389/fphar.2016.00343
NLM
Peres FF, Levin R, Suiama MA, Diana MC, Gouvêa DA, Almeida V, Santos CM, Lungato L, Zuardi AW, Hallak JEC, Crippa JA de S, D’Almeida V, Silva RH, Abílio VC. Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 nov. 15 ] Available from: https://doi.org/10.3389/fphar.2016.00343
Vancouver
Peres FF, Levin R, Suiama MA, Diana MC, Gouvêa DA, Almeida V, Santos CM, Lungato L, Zuardi AW, Hallak JEC, Crippa JA de S, D’Almeida V, Silva RH, Abílio VC. Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 nov. 15 ] Available from: https://doi.org/10.3389/fphar.2016.00343
Artigo de periodico-carta/editorial
Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia. [Carta] (2016)
Peres, F. F; Diana, M. C; Suiama, M. A; Justi, V; Almeida, V; Bressan, R. A; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Abilio, V. C
Source: Schizophrenia Research. Unidade: FMRP
Subjects: ESQUIZOFRENIA, MODELOS ANIMAIS, FÁRMACOS PSICOTRÓPICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERES, F. F et al. Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia. [Carta]. Schizophrenia Research. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.schres.2016.02.004. Acesso em: 15 nov. 2024. , 2016
APA
Peres, F. F., Diana, M. C., Suiama, M. A., Justi, V., Almeida, V., Bressan, R. A., et al. (2016). Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia. [Carta]. Schizophrenia Research. Amsterdam: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.schres.2016.02.004
NLM
Peres FF, Diana MC, Suiama MA, Justi V, Almeida V, Bressan RA, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia. [Carta] [Internet]. Schizophrenia Research. 2016 ; 172( 1-3): 220-221.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.schres.2016.02.004
Vancouver
Peres FF, Diana MC, Suiama MA, Justi V, Almeida V, Bressan RA, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia. [Carta] [Internet]. Schizophrenia Research. 2016 ; 172( 1-3): 220-221.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.schres.2016.02.004
Artigo de periodico
Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy (2016)
Peres, Fernanda F.; Levin, Raquel; Almeida, Valéria; Zuardi, Antônio Waldo; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Abilio, Vanessa C.
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: CANABINOIDES, MODELOS ANIMAIS, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERES, Fernanda F. et al. Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy. Frontiers in Pharmacology, v. 7, 2016Tradução . . Disponível em: https://doi.org/10.3389/fphar.2016.00303. Acesso em: 15 nov. 2024.
APA
Peres, F. F., Levin, R., Almeida, V., Zuardi, A. W., Hallak, J. E. C., Crippa, J. A. de S., & Abilio, V. C. (2016). Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy. Frontiers in Pharmacology, 7. doi:10.3389/fphar.2016.00303
NLM
Peres FF, Levin R, Almeida V, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 nov. 15 ] Available from: https://doi.org/10.3389/fphar.2016.00303
Vancouver
Peres FF, Levin R, Almeida V, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the SHR animal model: implications for schizophrenia pharmacotherapy [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 nov. 15 ] Available from: https://doi.org/10.3389/fphar.2016.00303
Artigo de periodico
Cannabidiol and sodium nitroprusside: two novel neuromodulatory pharmacological interventions to treat and prevent psychosis (2015)
Crippa, José Alexandre de Souza; Hallak, Jaime Eduardo Cecílio; Abilio, Vanessa Costhek; Lacerda, Acioly Luiz Tavares; Zuardi, Antonio Waldo
Source: CNS & Neurological Disorders - Drug Targets. Unidade: FMRP
Subjects: CANABINOIDES, TRANSTORNOS PSICÓTICOS, ESQUIZOFRENIA, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRIPPA, José Alexandre de Souza et al. Cannabidiol and sodium nitroprusside: two novel neuromodulatory pharmacological interventions to treat and prevent psychosis. CNS & Neurological Disorders - Drug Targets, v. 14, n. 8, p. 970-978, 2015Tradução . . Disponível em: https://doi.org/10.2174/1871527314666150909113930. Acesso em: 15 nov. 2024.
APA
Crippa, J. A. de S., Hallak, J. E. C., Abilio, V. C., Lacerda, A. L. T., & Zuardi, A. W. (2015). Cannabidiol and sodium nitroprusside: two novel neuromodulatory pharmacological interventions to treat and prevent psychosis. CNS & Neurological Disorders - Drug Targets, 14( 8), 970-978. doi:10.2174/1871527314666150909113930
NLM
Crippa JA de S, Hallak JEC, Abilio VC, Lacerda ALT, Zuardi AW. Cannabidiol and sodium nitroprusside: two novel neuromodulatory pharmacological interventions to treat and prevent psychosis [Internet]. CNS & Neurological Disorders - Drug Targets. 2015 ; 14( 8): 970-978.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2174/1871527314666150909113930
Vancouver
Crippa JA de S, Hallak JEC, Abilio VC, Lacerda ALT, Zuardi AW. Cannabidiol and sodium nitroprusside: two novel neuromodulatory pharmacological interventions to treat and prevent psychosis [Internet]. CNS & Neurological Disorders - Drug Targets. 2015 ; 14( 8): 970-978.[citado 2024 nov. 15 ] Available from: https://doi.org/10.2174/1871527314666150909113930
Artigo de periodico
Depressive symptoms and alcohol correlates among Brazilians aged 14 years and older: a cross-sectional study (2014)
Coelho, Cassiano L. S.; Laranjeira, Ronaldo R; Santos, Jair Lício Ferreira; Pinsky, Ilana; Zaleski, Marcos; Caetano, Raul; Crippa, José Alexandre de Souza
Source: Substance Abuse Treatment, Prevention, and Policy. Unidade: FMRP
Subjects: DEPRESSÃO, ALCOOLISMO, EPIDEMIOLOGIA, COMORBIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COELHO, Cassiano L. S. et al. Depressive symptoms and alcohol correlates among Brazilians aged 14 years and older: a cross-sectional study. Substance Abuse Treatment, Prevention, and Policy, v. 9, 2014Tradução . . Disponível em: https://doi.org/10.1186/1747-597X-9-29. Acesso em: 15 nov. 2024.
APA
Coelho, C. L. S., Laranjeira, R. R., Santos, J. L. F., Pinsky, I., Zaleski, M., Caetano, R., & Crippa, J. A. de S. (2014). Depressive symptoms and alcohol correlates among Brazilians aged 14 years and older: a cross-sectional study. Substance Abuse Treatment, Prevention, and Policy, 9. doi:10.1186/1747-597X-9-29
NLM
Coelho CLS, Laranjeira RR, Santos JLF, Pinsky I, Zaleski M, Caetano R, Crippa JA de S. Depressive symptoms and alcohol correlates among Brazilians aged 14 years and older: a cross-sectional study [Internet]. Substance Abuse Treatment, Prevention, and Policy. 2014 ; 9[citado 2024 nov. 15 ] Available from: https://doi.org/10.1186/1747-597X-9-29
Vancouver
Coelho CLS, Laranjeira RR, Santos JLF, Pinsky I, Zaleski M, Caetano R, Crippa JA de S. Depressive symptoms and alcohol correlates among Brazilians aged 14 years and older: a cross-sectional study [Internet]. Substance Abuse Treatment, Prevention, and Policy. 2014 ; 9[citado 2024 nov. 15 ] Available from: https://doi.org/10.1186/1747-597X-9-29
Artigo de periodico
NMDA and AMPA/Kainate glutamatergic receptors in the prelimbic medial prefrontal cortex modulate the elaborated defensive behavior and innate fear-induced antinociception elicited by 'GABA IND.A' receptor blockade in the medial hypothalamus (2014)
Freitas, Renato Leonardo de; Salgado-Rohner, Carlos José; Biagioni, Audrey Francisco; Medeiros, Priscila; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Coimbra, Norberto Cysne
Source: Cerebral Cortex. Unidade: FMRP
Subjects: RECEPTORES, HIPOTÁLAMO, NOCICEPTORES, PÂNICO, GABA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, Renato Leonardo de et al. NMDA and AMPA/Kainate glutamatergic receptors in the prelimbic medial prefrontal cortex modulate the elaborated defensive behavior and innate fear-induced antinociception elicited by 'GABA IND.A' receptor blockade in the medial hypothalamus. Cerebral Cortex, v. 24, p. 1518-1528, 2014Tradução . . Disponível em: https://doi.org/10.1093/cercor/bht001. Acesso em: 15 nov. 2024.
APA
Freitas, R. L. de, Salgado-Rohner, C. J., Biagioni, A. F., Medeiros, P., Hallak, J. E. C., Crippa, J. A. de S., & Coimbra, N. C. (2014). NMDA and AMPA/Kainate glutamatergic receptors in the prelimbic medial prefrontal cortex modulate the elaborated defensive behavior and innate fear-induced antinociception elicited by 'GABA IND.A' receptor blockade in the medial hypothalamus. Cerebral Cortex, 24, 1518-1528. doi:10.1093/cercor/bht001
NLM
Freitas RL de, Salgado-Rohner CJ, Biagioni AF, Medeiros P, Hallak JEC, Crippa JA de S, Coimbra NC. NMDA and AMPA/Kainate glutamatergic receptors in the prelimbic medial prefrontal cortex modulate the elaborated defensive behavior and innate fear-induced antinociception elicited by 'GABA IND.A' receptor blockade in the medial hypothalamus [Internet]. Cerebral Cortex. 2014 ; 24 1518-1528.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1093/cercor/bht001
Vancouver
Freitas RL de, Salgado-Rohner CJ, Biagioni AF, Medeiros P, Hallak JEC, Crippa JA de S, Coimbra NC. NMDA and AMPA/Kainate glutamatergic receptors in the prelimbic medial prefrontal cortex modulate the elaborated defensive behavior and innate fear-induced antinociception elicited by 'GABA IND.A' receptor blockade in the medial hypothalamus [Internet]. Cerebral Cortex. 2014 ; 24 1518-1528.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1093/cercor/bht001
Artigo de periodico
Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain (2014)
Levin, Raquel; Peres, Fernanda F.; Almeida, Valéria; Calzavara, Mariana B.; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Abílio, Vanessa C.
Source: Frontiers in Pharmacology. Unidade: FMRP
Subjects: ESQUIZOFRENIA, TERAPÊUTICA MÉDICA, CANNABIS, SISTEMA NERVOSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEVIN, Raquel et al. Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain. Frontiers in Pharmacology, v. 5, 2014Tradução . . Disponível em: https://doi.org/10.3389/fphar.2014.00010. Acesso em: 15 nov. 2024.
APA
Levin, R., Peres, F. F., Almeida, V., Calzavara, M. B., Zuardi, A. W., Hallak, J. E. C., et al. (2014). Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain. Frontiers in Pharmacology, 5. doi:10.3389/fphar.2014.00010
NLM
Levin R, Peres FF, Almeida V, Calzavara MB, Zuardi AW, Hallak JEC, Crippa JA de S, Abílio VC. Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain [Internet]. Frontiers in Pharmacology. 2014 ; 5[citado 2024 nov. 15 ] Available from: https://doi.org/10.3389/fphar.2014.00010
Vancouver
Levin R, Peres FF, Almeida V, Calzavara MB, Zuardi AW, Hallak JEC, Crippa JA de S, Abílio VC. Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of schizophrenia: the SHR strain [Internet]. Frontiers in Pharmacology. 2014 ; 5[citado 2024 nov. 15 ] Available from: https://doi.org/10.3389/fphar.2014.00010
Artigo de periodico
Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: the SHR strain (2014)
Almeida, Valéria; Peres, Fernanda F.; Levin, Raquel; Suiama, Mayra A.; Calzavara, Mariana B.; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Abilio, Vanessa Costhek
Source: Schizophrenia Research. Unidade: FMRP
Subjects: CANNABIS (COMPONENTES), MODELOS ANIMAIS DE DOENÇAS, ESQUIZOFRENIA (QUIMIOTERAPIA;FISIOPATOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Valéria et al. Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: the SHR strain. Schizophrenia Research, v. 153, n. 1-3, p. 150-159, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.schres.2014.01.039. Acesso em: 15 nov. 2024.
APA
Almeida, V., Peres, F. F., Levin, R., Suiama, M. A., Calzavara, M. B., Zuardi, A. W., et al. (2014). Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: the SHR strain. Schizophrenia Research, 153( 1-3), 150-159. doi:10.1016/j.schres.2014.01.039
NLM
Almeida V, Peres FF, Levin R, Suiama MA, Calzavara MB, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: the SHR strain [Internet]. Schizophrenia Research. 2014 ; 153( 1-3): 150-159.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.schres.2014.01.039
Vancouver
Almeida V, Peres FF, Levin R, Suiama MA, Calzavara MB, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Effects of cannabinoid and vanilloid drugs on positive and negative-like symptoms on an animal model of schizophrenia: the SHR strain [Internet]. Schizophrenia Research. 2014 ; 153( 1-3): 150-159.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.schres.2014.01.039
Artigo de periodico
Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test (2013)
Almeida, Valéria; Levin, Raquel; Peres, Fernanda Fiel; Niigaki, Suzy T.; Calzavara, Mariana B.; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Abílio, Vanessa C.
Source: Progress in Neuro-Psychopharmacology and Biological Psychiatry. Unidade: FMRP
Subjects: CANNABIS, ANSIEDADE, ESQUIZOFRENIA, INTERAÇÃO SOCIAL (COMPORTAMENTO SOCIAL)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Valéria et al. Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test. Progress in Neuro-Psychopharmacology and Biological Psychiatry, v. 41, p. 30-35, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2012.10.024. Acesso em: 15 nov. 2024.
APA
Almeida, V., Levin, R., Peres, F. F., Niigaki, S. T., Calzavara, M. B., Zuardi, A. W., et al. (2013). Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 41, 30-35. doi:10.1016/j.pnpbp.2012.10.024
NLM
Almeida V, Levin R, Peres FF, Niigaki ST, Calzavara MB, Zuardi AW, Hallak JEC, Crippa JA de S, Abílio VC. Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2013 ; 41 30-35.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.pnpbp.2012.10.024
Vancouver
Almeida V, Levin R, Peres FF, Niigaki ST, Calzavara MB, Zuardi AW, Hallak JEC, Crippa JA de S, Abílio VC. Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test [Internet]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2013 ; 41 30-35.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.pnpbp.2012.10.024
Artigo de periodico
Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats (2013)
Chagas, Marcos Hortes Nisihara; Crippa, José Alexandre de Souza; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecílio; Machado-de-Sousa, João Paulo; Hirotsu, Camila; Maia, Lucas; Tufik, Sergio; Andersen, Monica Levy
Source: Journal of Psychopharmacology. Unidade: FMRP
Subjects: ANTIDEPRESSIVOS (FARMACOLOGIA), CANNABIS (COMPONENTES), SONO (EFEITOS DE DROGAS), HIPNÓTICOS, SEDATIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAGAS, Marcos Hortes Nisihara et al. Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats. Journal of Psychopharmacology, v. 27, n. 3, p. 312-316, 2013Tradução . . Disponível em: https://doi.org/10.1177/0269881112474524. Acesso em: 15 nov. 2024.
APA
Chagas, M. H. N., Crippa, J. A. de S., Zuardi, A. W., Hallak, J. E. C., Machado-de-Sousa, J. P., Hirotsu, C., et al. (2013). Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats. Journal of Psychopharmacology, 27( 3), 312-316. doi:10.1177/0269881112474524
NLM
Chagas MHN, Crippa JA de S, Zuardi AW, Hallak JEC, Machado-de-Sousa JP, Hirotsu C, Maia L, Tufik S, Andersen ML. Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats [Internet]. Journal of Psychopharmacology. 2013 ; 27( 3): 312-316.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1177/0269881112474524
Vancouver
Chagas MHN, Crippa JA de S, Zuardi AW, Hallak JEC, Machado-de-Sousa JP, Hirotsu C, Maia L, Tufik S, Andersen ML. Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats [Internet]. Journal of Psychopharmacology. 2013 ; 27( 3): 312-316.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1177/0269881112474524
Artigo de periodico
Antipsychotic profile of cannabidiol and rimonabant in an animal model of emotional context processing in schizophrenia (2012)
Levin, Raquel; Almeida, Valéria; Peres, Fernanda Fiel; Calzavara, Mariana Bendlin; Silva, Neide Derci da; Suiama, Mayra Akimi; Niigaki, Suzie Tamie; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Abilio, Vanessa Costhek
Source: Current Pharmaceutical Design. Unidade: FMRP
Subjects: CANNABIS (COMPONENTES;FARMACOLOGIA), ANTAGONISMO DE DROGAS, MODELOS ANIMAIS DE DOENÇAS, ESQUIZOFRENIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEVIN, Raquel et al. Antipsychotic profile of cannabidiol and rimonabant in an animal model of emotional context processing in schizophrenia. Current Pharmaceutical Design, v. 18, n. 32, p. 4960-4965, 2012Tradução . . Acesso em: 15 nov. 2024.
APA
Levin, R., Almeida, V., Peres, F. F., Calzavara, M. B., Silva, N. D. da, Suiama, M. A., et al. (2012). Antipsychotic profile of cannabidiol and rimonabant in an animal model of emotional context processing in schizophrenia. Current Pharmaceutical Design, 18( 32), 4960-4965.
NLM
Levin R, Almeida V, Peres FF, Calzavara MB, Silva ND da, Suiama MA, Niigaki ST, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Antipsychotic profile of cannabidiol and rimonabant in an animal model of emotional context processing in schizophrenia. Current Pharmaceutical Design. 2012 ; 18( 32): 4960-4965.[citado 2024 nov. 15 ]
Vancouver
Levin R, Almeida V, Peres FF, Calzavara MB, Silva ND da, Suiama MA, Niigaki ST, Zuardi AW, Hallak JEC, Crippa JA de S, Abilio VC. Antipsychotic profile of cannabidiol and rimonabant in an animal model of emotional context processing in schizophrenia. Current Pharmaceutical Design. 2012 ; 18( 32): 4960-4965.[citado 2024 nov. 15 ]
Trabalho de evento-resumo
Cannabidiol: an anxiolytic or an antipsychotic new drug? (2011)
Peres, F. F.; Almeida, V.; Levin, R.; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecílio; Crippa, José Alexandre de Souza; Niigaki, S. T.; Abílio, V. C.
Source: Programa. Conference titles: Reunião Anual da Federação de Sociedades de Biologia Experimental (FeSBE). Unidade: FMRP
Subjects: ESQUIZOFRENIA, INTERAÇÃO SOCIAL (COMPORTAMENTO SOCIAL), CANNABIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PERES, F. F. et al. Cannabidiol: an anxiolytic or an antipsychotic new drug? 2011, Anais.. São Paulo: FeSBE, 2011. . Acesso em: 15 nov. 2024.
APA
Peres, F. F., Almeida, V., Levin, R., Zuardi, A. W., Hallak, J. E. C., Crippa, J. A. de S., et al. (2011). Cannabidiol: an anxiolytic or an antipsychotic new drug? In Programa. São Paulo: FeSBE.
NLM
Peres FF, Almeida V, Levin R, Zuardi AW, Hallak JEC, Crippa JA de S, Niigaki ST, Abílio VC. Cannabidiol: an anxiolytic or an antipsychotic new drug? Programa. 2011 ;[citado 2024 nov. 15 ]
Vancouver
Peres FF, Almeida V, Levin R, Zuardi AW, Hallak JEC, Crippa JA de S, Niigaki ST, Abílio VC. Cannabidiol: an anxiolytic or an antipsychotic new drug? Programa. 2011 ;[citado 2024 nov. 15 ]
Trabalho de evento-resumo
Effects of harmine on fear conditioning of rats kept in homogeneous or heterogeneous cages (2011)
Libânio, T. C.; Diana, M.; Derci, N.; Calzavara, M. B.; Zuardi, Antonio Waldo; Crippa, José Alexandre de Souza; Hallak, Jaime Eduardo Cecílio; Abílio, V. C.
Source: Programa. Conference titles: Reunião Anual da Federação de Sociedades de Biologia Experimental (FeSBE). Unidade: FMRP
Subjects: CHÁ (EFEITOS), NEUROCIÊNCIAS, COMPORTAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIBÂNIO, T. C. et al. Effects of harmine on fear conditioning of rats kept in homogeneous or heterogeneous cages. 2011, Anais.. São Paulo: FeSBE, 2011. . Acesso em: 15 nov. 2024.
APA
Libânio, T. C., Diana, M., Derci, N., Calzavara, M. B., Zuardi, A. W., Crippa, J. A. de S., et al. (2011). Effects of harmine on fear conditioning of rats kept in homogeneous or heterogeneous cages. In Programa. São Paulo: FeSBE.
NLM
Libânio TC, Diana M, Derci N, Calzavara MB, Zuardi AW, Crippa JA de S, Hallak JEC, Abílio VC. Effects of harmine on fear conditioning of rats kept in homogeneous or heterogeneous cages. Programa. 2011 ;[citado 2024 nov. 15 ]
Vancouver
Libânio TC, Diana M, Derci N, Calzavara MB, Zuardi AW, Crippa JA de S, Hallak JEC, Abílio VC. Effects of harmine on fear conditioning of rats kept in homogeneous or heterogeneous cages. Programa. 2011 ;[citado 2024 nov. 15 ]

USP Schools

ReP

Filtros

Authors

Date published

Subjects

Source title

Indexado em